NEUTROPHIL-TO-LYMPHOCYTE RATIO IS ASSOCIATED WITH SENSITIVITY TO PLATINUM-BASED CHEMOTHERAPY AND PROGNOSIS FOR ADVANCED OVARIAN SEROUS CARCINOMA

被引:0
|
作者
Shimomura, M. [1 ]
Fukuda, T. [1 ]
Yamauchi, M. [1 ]
Kasai, M. [1 ]
Hashiguchi, Y. [1 ]
Ichimura, T. [1 ]
Yasui, T. [1 ]
Sumi, T. [1 ]
机构
[1] Osaka City Univ, Grad Sch Med, Obstet & Gynecol, Osaka, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IGCS8-0614
引用
收藏
页码:834 / 834
页数:1
相关论文
共 50 条
  • [1] Preoperative neutrophil-to-lymphocyte ratio predicts response to first-line platinum-based chemotherapy and prognosis in serous ovarian cancer
    Wang, Ying
    Liu, Ping
    Xu, Yan
    Zhang, Weihao
    Tong, Lina
    Guo, Zhi
    Ni, Hong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (02) : 255 - 262
  • [2] Preoperative neutrophil-to-lymphocyte ratio predicts response to first-line platinum-based chemotherapy and prognosis in serous ovarian cancer
    Ying Wang
    Ping Liu
    Yan Xu
    Weihao Zhang
    Lina Tong
    Zhi Guo
    Hong Ni
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 255 - 262
  • [3] FYN expression is associated with sensitivity to platinum-based chemotherapy for ovarian serous carcinoma
    Uchikura, Eijiro
    Fukuda, Takeshi
    Noda, Takuya
    Awazu, Yuichiro
    Nanno, Shigenori
    Imai, Kenji
    Wada, Takuma
    Yamauchi, Makoto
    Yasui, Tomoyo
    Sumi, Toshiyuki
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A206 - A207
  • [4] NEUTROPHIL-TO-LYMPHOCYTE RATIO PREDICTS SURVIVAL IN HIGH-GRADE OVARIAN CANCER TREATED WITH PLATINUM-BASED CHEMOTHERAPY
    Lutrino, E.
    Fontanella, C.
    Andreetta, C.
    Orlando, L.
    Rihawi, K.
    Quaranta, A.
    Bozza, C.
    D'Amico, M.
    Garattini, S.
    Mazzoni, E.
    Merlo, V.
    Chetri, M.
    Ermacora, P.
    Caliolo, C.
    Calvani, N.
    Cinieri, S.
    Sacco, C.
    Fasola, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1273 - 1273
  • [5] Expression of UCP2 is associated with the sensitivity to platinum-based chemotherapy for ovarian serous carcinoma
    Inoue, Yuta
    Fukuda, Takeshi
    Kawanishi, Masaru
    Shimomura, Masahiro
    Wada, Takuma
    Yamauchi, Makoto
    Yasui, Tomoyo
    Sumi, Toshiyuki
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 : S9 - S9
  • [6] Expression of UCP2 is associated with sensitivity to platinum-based chemotherapy for ovarian serous carcinoma
    Kawanishi, Masaru
    Fukuda, Takeshi
    Shimomura, Masahiro
    Inoue, Yuta
    Wada, Takuma
    Tasaka, Reiko
    Yasui, Tomoyo
    Sumi, Toshiyuki
    ONCOLOGY LETTERS, 2018, 15 (06) : 9923 - 9928
  • [7] Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy
    Miao, Yi
    Yan, Qin
    Li, Shuangdi
    Li, Bilan
    Feng, Youji
    CANCER BIOMARKERS, 2016, 17 (01) : 33 - 40
  • [8] Neutrophil-to-lymphocyte ratio as a prognostic factor in advanced stage ovarian carcinoma treated with neoadjuvant chemotherapy
    Eitan, R.
    Salman, L.
    Sabah, G.
    Jakobson-Setton, A.
    Raban, O.
    Yeoshoua, E.
    Tsoref, D.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 269 - 270
  • [9] Neutrophil-to-lymphocyte ratio as a prognostic factor in advanced stage ovarian carcinoma treated with neoadjuvant chemotherapy
    Salman, Lina
    Sabah, Gad
    Jakobson-Setton, Ariella
    Raban, Oded
    Yeoshoua, Effi
    Eitan, Ram
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2020, 148 (01) : 102 - 106
  • [10] Role of Fyn expression in predicting the sensitivity to platinum-based chemotherapy in patients with ovarian serous carcinoma
    Uchikura, Eijiro
    Fukuda, Takeshi
    Sengiku, Tomoki
    Noda, Takuya
    Awazu, Yuichiro
    Wada, Takuma
    Tasaka, Reiko
    Yamauchi, Makoto
    Yasui, Tomoyo
    Sumi, Toshiyuki
    ONCOLOGY LETTERS, 2024, 28 (05)